Q4 2023 Holdings
Filed 2024-02-13 | 7 holdings | $203.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $66.8M | 4,425,784 | 32.8% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $65.9M | 4,951,303 | 32.4% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $30.0M | 2,738,785 | 14.7% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $16.5M | 4,284,172 | 8.1% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $16.4M | 2,242,636 | 8.0% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $4.4M | 5,555,461 | 2.2% |
| Harpoon Therapeutics, Inc. | Common | 41358P205 | $3.6M | 313,136 | 1.7% |